Designed for screening
Improve breast cancer detection by 35.7 percent over mammography alone1
Remarkable image quality
Look differently at dense breast tissue with advanced interpretation tools
AI Assistant
Helps to detect and characterize breast lesions for clinical confidence
Approximately 40% of women have dense breasts2, one of the strongest common risk factors for developing breast cancer3. Clinical evidence is growing about the effectiveness of ultrasound for finding small, node-negative, invasive cancers missed by mammography4. Invenia ABUS 2.0 supplemental imaging is designed for the screening environment, specifically for dense breast imaging.
The new FDA mandate highlights the importance of supplemental image screening (like Invenia ABUS 2.0) in women with dense breasts and equips patients to make informed decisions with their provider about their breast health. In this new white paper, Dr. Raymond Kohne, Chief of Imaging at State of Franklin, tells his emotional story on why he has implemented a personalized ABUS program for dense breasts and his motivation in working hard to get the dense breast legislation passed in his home state of Tennessee to help his achieve his goal of “making a difference, not a diagnosis."
*The Invenia ABUS 2.0 device is not designed for use in a mobile environment unless it is installed using the Mobile ABUS fixation system.